Skip Navigation

Cardiovascular Research 2000 47(4):726-737; doi:10.1016/S0008-6363(00)00141-3
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Thuringer, D.
Right arrow Articles by Frelin, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thuringer, D.
Right arrow Articles by Frelin, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Cardiac capillary cells release biologically active nitric oxide at an early stage of in vitro development

Dominique Thuringera,*, Catherine Rucker-Martinb and Christian Frelina

aInstitut de Pharmacologie Moléculaire et Cellulaire, CNRS UPR411, 660 route des Lucioles, Sophia Antipolis, 06560 Valbonne, France
bCNRS ESA8078, Departement de Recherche Médicale, CCML 133 Avenue de la Résistance, 92350 Le Plessis-Robinson, France

* Corresponding author. Tel.: +33-4-9395-7744; fax: +33-4-9395-7708 thuringer{at}ipmc.cnrs.fr

Objective: Coronary microvascular endothelial cells (EC) may regulate the myocardial contractile function by releasing cardioactive agents such as nitric oxide (NO). However, understanding of these regulatory mechanisms is complicated by the fact that EC exhibit marked phenotypic changes, such as the loss of endothelial NO synthase (eNOS), when they are placed into culture. Recently, it has been shown that eNOS gene expression is regulated by specific cell–cell interactions with mural cells depending on vascular beds. Since EC and pericytes (PL) are closely associated in capillaries, we have enzymatically isolated these cells from rat hearts to develop a primary culture of capillary cells favoring the re-establishment of cell interactions in vitro. Methods: Expression of transcripts for both eNOS and the inducible isoform (iNOS), was evaluated by using reverse transcription, polymerase chain reaction and Southern blot analysis. Expression of NOS proteins was detected with specific rhodamine-labeled antibodies. Production of NO was assessed (i) from nitrite measurements in culture supernatants by the Griess reaction, and (ii) from its antiproliferative action on cardiac fibroblasts (FIB) in non-contacted cocultures (reporter-cell bioassay) compared to that of sodium nitroprusside in homotypic FIB cultures. Fura-2 fluorescence was used to measure agonist-induced changes in cytosolic free calcium levels. Results: In our heterotypic cultures, EC firstly proliferated to form spots of monolayers (i.e. first phase) before to be covered by PL on the following days (i.e. second phase). The data from RT-PCR analysis demonstrate the presence of mRNAs of both eNOS and iNOS at all developmental stages of the culture. However, eNOS protein was only detected and restricted to EC. During the first phase of cell growth (5–8 days), cells released nitrite and a labile factor, clearly identified as NO, that inhibited the FIB proliferation in reporter-cell bioassay. These effects, not observed during the second phase of cell growth (15–20 days), were prevented by hemoglobin (50 µM) and by N{omega}-nitro-L-arginine methyl ester (L-NAME; 100 µM). At the two periods of culture, EC increased rapidly their cytosolic Ca2+ concentration in response to bradykinin (10 nM). However, this calcium response was associated with an increase in nitrite production only in older cultures. Conclusions: Our data indicate that heterotypic cultures of native capillary cells preserve the eNOS expression by EC. This enzyme is basally active at an early stage of in vitro development, and then becomes activatable by a Ca2+-mobilizing agonist. NO released by growing EC downregulates the proliferation of cardiac FIB, an effect which could be important in the cardiovascular plasticity.

KEYWORDS Angiogenesis; Gene expression; Coronary circulation; Capillaries; Cell culture/isolation; Nitric oxide


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
X. F Figueroa, D. R Gonzalez, A. D Martinez, W. N Duran, and M. P Boric
ACh-induced endothelial NO synthase translocation, NO release and vasodilatation in the hamster microcirculation in vivo
J. Physiol., November 1, 2002; 544(3): 883 - 896.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. A. Birder, M. L. Nealen, S. Kiss, W. C. de Groat, M. J. Caterina, E. Wang, G. Apodaca, and A. J. Kanai
beta -Adrenoceptor Agonists Stimulate Endothelial Nitric Oxide Synthase in Rat Urinary Bladder Urothelial Cells
J. Neurosci., September 15, 2002; 22(18): 8063 - 8070.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Thuringer, L. Maulon, and C. Frelin
Rapid Transactivation of the Vascular Endothelial Growth Factor Receptor KDR/Flk-1 by the Bradykinin B2 Receptor Contributes to Endothelial Nitric-oxide Synthase Activation in Cardiac Capillary Endothelial Cells
J. Biol. Chem., January 11, 2002; 277(3): 2028 - 2032.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.